Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC).
Purity:
>99.0%, Endotoxin < 1 EU/µg
CAS Number:
[1912424-97-5]
* VAT and and shipping costs not included. Errors and price changes excepted